Both kinases have been reported to interact with and phosphorylate tau directly (65, 66, 67, 68) and to activate glycogen synthase kinase 3β, one of the most well-characterized tau kinases in AD (69, 70, 71). Here, MAPT is linked to Alzheimer disease.